Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
18 06 2019
Historique:
received: 26 10 2018
revised: 04 02 2019
accepted: 11 04 2019
pubmed: 12 5 2019
medline: 2 11 2019
entrez: 12 5 2019
Statut: ppublish

Résumé

Inflammasome activation and subsequent pyroptosis are critical defense mechanisms against microbes. However, overactivation of inflammasome leads to death of the host. Although recent studies have uncovered the mechanism of pyroptosis following inflammasome activation, how pyroptotic cell death drives pathogenesis, eventually leading to death of the host, is unknown. Here, we identified inflammasome activation as a trigger for blood clotting through pyroptosis. We have shown that canonical inflammasome activation by the conserved type III secretion system (T3SS) rod proteins from Gram-negative bacteria or noncanonical inflammasome activation by lipopolysaccharide (LPS) induced systemic blood clotting and massive thrombosis in tissues. Following inflammasome activation, pyroptotic macrophages released tissue factor (TF), an essential initiator of coagulation cascades. Genetic or pharmacological inhibition of TF abolishes inflammasome-mediated blood clotting and protects against death. Our data reveal that blood clotting is the major cause of host death following inflammasome activation and demonstrate that inflammasome bridges inflammation with thrombosis.

Identifiants

pubmed: 31076358
pii: S1074-7613(19)30183-9
doi: 10.1016/j.immuni.2019.04.003
pmc: PMC6791531
mid: NIHMS1528326
pii:
doi:

Substances chimiques

Biomarkers 0
Inflammasomes 0
Lipopolysaccharides 0
Thromboplastin 9035-58-9
Caspases EC 3.4.22.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1401-1411.e4

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM121796
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL123927
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI103717
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI137020
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142640
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM132443
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI142063
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM085231
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM127211
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103527
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL145117
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Blood Rev. 2016 Jul;30(4):257-61
pubmed: 26776504
J Clin Invest. 1994 Jan;93(1):114-20
pubmed: 8282778
J Clin Invest. 2017 Nov 1;127(11):4124-4135
pubmed: 28990935
Science. 2016 Jun 3;352(6290):1232-6
pubmed: 27103670
Nature. 2011 Sep 14;477(7366):596-600
pubmed: 21918512
J Exp Med. 2016 May 2;213(5):647-56
pubmed: 27114610
Indian J Anaesth. 2014 Sep;58(5):603-8
pubmed: 25535423
J Exp Med. 2018 Mar 5;215(3):827-840
pubmed: 29432122
J Pharmacol Exp Ther. 1984 Jan;228(1):240-4
pubmed: 6319669
Cell. 2010 Mar 19;140(6):821-32
pubmed: 20303873
J Clin Invest. 1998 May 1;101(9):1983-91
pubmed: 9576763
Inflammation. 2018 Oct;41(5):1569-1581
pubmed: 29956069
Mol Microbiol. 1995 Feb;15(4):661-6
pubmed: 7783638
Blood. 2017 Mar 9;129(10):1357-1367
pubmed: 28073784
J Biol Chem. 1981 Aug 25;256(16):8324-31
pubmed: 6790539
Cell Rep. 2018 Aug 7;24(6):1425-1433
pubmed: 30089254
Nature. 2014 Oct 9;514(7521):187-92
pubmed: 25119034
Science. 2013 Sep 13;341(6151):1246-9
pubmed: 23887873
J Clin Invest. 2015 Apr;125(4):1471-84
pubmed: 25705884
Cell. 2012 Aug 3;150(3):606-19
pubmed: 22819539
J Cell Biol. 2012 Sep 3;198(5):773-83
pubmed: 22945932
J Intensive Care. 2014 Feb 20;2(1):15
pubmed: 25520831
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
Science. 1983 Dec 9;222(4628):1129-32
pubmed: 6648524
Immunity. 2018 Jan 16;48(1):35-44.e6
pubmed: 29195811
Thromb Haemost. 2004 Sep;92(3):444-50
pubmed: 15351839
N Engl J Med. 2013 Aug 29;369(9):840-51
pubmed: 23984731
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3076-80
pubmed: 20133635
JAMA. 1995 Jan 11;273(2):117-23
pubmed: 7799491
N Engl J Med. 1999 Aug 19;341(8):586-92
pubmed: 10451465
J Infect Chemother. 2014 Feb;20(2):115-20
pubmed: 24462442
Cell Res. 2015 Dec;25(12):1285-98
pubmed: 26611636
Nat Biotechnol. 2011 Oct 23;29(11):1028-33
pubmed: 22020385
Nature. 2012 Oct 4;490(7418):107-11
pubmed: 22902502
Cell Microbiol. 2006 Nov;8(11):1812-25
pubmed: 16824040
Immunol Rev. 2015 May;265(1):130-42
pubmed: 25879289
Blood. 2010 Aug 5;116(5):806-14
pubmed: 20410508
Nature. 2015 Oct 29;526(7575):666-71
pubmed: 26375259
Circ Shock. 1991 Mar;33(3):127-34
pubmed: 2044206
Crit Care. 2013 Jun 20;17(3):R111
pubmed: 23787004
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7858-63
pubmed: 27339137
Blood. 2000 Jul 15;96(2):554-9
pubmed: 10887118
Cell. 2014 May 22;157(5):1013-22
pubmed: 24855941
Nature. 2011 Oct 16;479(7371):117-21
pubmed: 22002608
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Nat Rev Immunol. 2013 Jun;13(6):397-411
pubmed: 23702978
Cell. 2016 May 19;165(5):1106-1119
pubmed: 27156449
EMBO J. 2016 Aug 15;35(16):1766-78
pubmed: 27418190
Cell. 1987 Jul 3;50(1):129-35
pubmed: 3297348
Nature. 2016 Jul 7;535(7610):111-6
pubmed: 27281216
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1851-6
pubmed: 23307811
Nat Commun. 2013;4:2657
pubmed: 24150174
Science. 2013 Sep 13;341(6151):1250-3
pubmed: 24031018
Nature. 2018 May;557(7703):62-67
pubmed: 29695864
Genesis. 2008 Aug;46(8):418-23
pubmed: 18693275
J Leukoc Biol. 2013 Mar;93(3):329-42
pubmed: 23136259
Nature. 2012 Oct 11;490(7419):288-91
pubmed: 22895188
Blood. 2008 Aug 15;112(4):1101-8
pubmed: 18559671
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):709-725
pubmed: 29437578
Science. 2016 Apr 1;352(6281):aaf2154
pubmed: 27034377
Nat Rev Dis Primers. 2016 Jun 02;2:16037
pubmed: 27250996
J Thromb Haemost. 2005 May;3(5):1098-9
pubmed: 15869619

Auteurs

Congqing Wu (C)

Saha Cardiovascular Research Center, College of Medicine, University of Kentucky, Lexington, KY, USA.

Wei Lu (W)

Department of Chemistry, College of Arts and Sciences, University of Kentucky, Lexington, KY, USA.

Yan Zhang (Y)

Saha Cardiovascular Research Center, College of Medicine, University of Kentucky, Lexington, KY, USA.

Guoying Zhang (G)

Saha Cardiovascular Research Center, College of Medicine, University of Kentucky, Lexington, KY, USA.

Xuyan Shi (X)

National Institute of Biological Sciences, Beijing, China.

Yohei Hisada (Y)

Division of Hematology and Oncology, Department of Medicine, McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Steven P Grover (SP)

Division of Hematology and Oncology, Department of Medicine, McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Xinyi Zhang (X)

Department of Chemistry, College of Arts and Sciences, University of Kentucky, Lexington, KY, USA.

Lan Li (L)

Department of Chemistry, College of Arts and Sciences, University of Kentucky, Lexington, KY, USA.

Binggang Xiang (B)

Saha Cardiovascular Research Center, College of Medicine, University of Kentucky, Lexington, KY, USA.

Jumei Shi (J)

Department of Hematology, Shanghai Tenth People's Hospital, Tongji University Cancer Center, Tongji University School of Medicine, Shanghai, China.

Xiang-An Li (XA)

Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY, USA.

Alan Daugherty (A)

Saha Cardiovascular Research Center, College of Medicine, University of Kentucky, Lexington, KY, USA; Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY, USA.

Susan S Smyth (SS)

Saha Cardiovascular Research Center, College of Medicine, University of Kentucky, Lexington, KY, USA; Veterans Affairs Medical Center, Lexington, KY, USA.

Daniel Kirchhofer (D)

Department of Early Discovery Biochemistry, Genentech, Inc., South San Francisco, CA, USA.

Toshihiko Shiroishi (T)

Mammalian Genetics Laboratory, Genetic Strains Research Center, National Institute of Genetics, Mishima, Shizuoka, Japan.

Feng Shao (F)

National Institute of Biological Sciences, Beijing, China.

Nigel Mackman (N)

Division of Hematology and Oncology, Department of Medicine, McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Yinan Wei (Y)

Department of Chemistry, College of Arts and Sciences, University of Kentucky, Lexington, KY, USA. Electronic address: yinan.wei@uky.edu.

Zhenyu Li (Z)

Saha Cardiovascular Research Center, College of Medicine, University of Kentucky, Lexington, KY, USA. Electronic address: zhenyuli08@uky.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH